Table 1.
Clinicobiological characteristics of the patients.
| Patients No. (%) | |
|---|---|
| Age | |
| >70 | 7 (50) |
| <70 | 7 (50) |
| Sex | |
| Male | 10 (71) |
| Female | 4 (29) |
| FAB | |
| M4 | 8 (57) |
| M5 | 4 (29) |
| M6 | 2 (14) |
| Disease status | |
| De novo | 3 (21)* |
| Secondary | 2 (14)** |
| Refractory | 4 (29) |
| Relapsed | 5 (36) |
| Previous lines of CHT |
|
| 1 | 4 |
| 2 | 1 |
| >2 | 4 |
| Peripheral blood blast count |
|
| <5 × 109/L | 9 (64) |
| >5 × 109/L | 5 (36) |
| Karyotype | |
| Intermediate | 10 (83) |
| Unfavorable | 2 (17) |
| Failure | 2 |
*Frails due to age higher than 75 years, one refused conventional chemotherapy.
**Secondary leukemia following myelodysplasia and not eligible for the available conventional protocols.